9 Meters Biopharma Inc. (NASDAQ:NMTR) currently has a daily average trading volume of 1.55M but it saw 30557592 shares traded on Tuesday. With a market cap of 73.91M USD, the company’s enterprise value now stands nearly at $66.37M. Stock’s current market price of $0.65 came rising about 16.53 while comparing to the previous closing price of $0.56. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.29 and as low as $0.37. In the recent trading on the day, stock has struck highest price mark of $0.75 while lowest mark touched by it was $0.588.

Taking a look at 20-day trading activity of 9 Meters Biopharma Inc. (NMTR) gives us an average price of $0.5193, while its current price level is -49.61% below from 52-week high level whereas it is 75.63% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.5545. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.85% during that period while stretching the period over a month that decreases to 9.79%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 66.06 which implies that the stock is in neutral territory.

Over the week, NMTR’s stock price is moving 27.63% up while it is 18.18% when we observe its performance for the past one month. Year-to-date it is 16.68% up and over the past year, the stock is showing a downside performance of -26.97%.

The latest quarterly earnings report issued by the company was for quarter ended 9/29/2019, when its quarterly earnings per share (EPS) of -$0.26 beaten by the consensus estimate of -$0.14 for the same.

Currently, 9 Meters Biopharma Inc.’s total number of outstanding shares is 78.59M with 10.24% of that held by the insiders while 2.73% of its common stock has been owned by the institutions. Stock’s beta reads -5.02. Stock has a price to book (P/B) ratio of 16.25.

A filing at the U.S. Securities and Exchange Commission revealed that Vanguard Total Stock Market Index came shrinking its share ownership by 0.00% in the 9 Meters Biopharma Inc. (NMTR) decreasing its stake to 0.38% with control over 0.0 shares in the company. As per SEC documents, Vanguard Total Stock Market Index shunned 514,938 of company’s common stock of worth $0.25 million as per recent closing price of the stock. Vanguard Total Stock Market Index is not the only institutional holder which restructured its stake in 9 Meters Biopharma Inc., as Vanguard Extended Market Index Fu dumped 200,245 shares of worth $95317.0 to bring its holdings to a total of 0.0 shares. In the most recent quarter, Fidelity Extended Market Index Fu came cutting its stake by 0.00% in the company and now holds 53980.0 or 0.04% of the company’s stake having worth of about 25694.0.